Pashtoon Kasi: Cholangiocarcinoma in the context of Randy Moss’ recent diagnosis
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, Orange County, shared on LinkedIn:
“I got to discuss about cholangiocarcinoma in the context of Randy Moss’ recent diagnosis with MedPage Today.
From immunotherapy now being standard of care for those with advanced/metastatic cancer, to an array of targeted therapies for those with actionable aberrations, cholangiocarcinoma is becoming a poster child for precision medicine.”
Dr. Pashtoon Kasi is the Medical Director of GI Medical Oncology at City of Hope, Orange County. Previously, Dr. Kasi served as an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Iowa, following positions as an Assistant Professor of Medicine and Oncology at both the University of Iowa and Mayo Clinic.
He also served as the Director of Colon Cancer Research and Director of Precision Medicine Research for Liquid Biopsies at Weill Cornell Medicine.
His research primarily focuses on “liquid biopsies,” particularly circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). Dr. Kasi is also recognized as an author and editor of several significant books, including “Research: What, Why, and How: A Treatise from Researchers to Researchers” and “Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies.”
His scholarly contributions extend to over 100 publications in esteemed peer-reviewed journals. He also received the Yvonne Award 2024 by OncoDaily in the “challenging the status quo” category.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023